Stream Your Event | Partners | Speakers CART ITEMS: - | CHECKOUT

or Log In

(recommended)

Share your favorite videos with friends
Comment on videos and join the conversation
Get personalized recommendations
Enjoy exclusive offers

Purchased a FORA.tv video on another website? Login here with the temporary account credentials included in your receipt.

Username or Email:
Password:
Forgot your password? Keep me logged in

Pay-Per-View
business
environment
politics
science
technology
culture

Preview

When I'm 164: If Anti-Aging Science Succeeds, Then What?

Watch Full Video | previews

Litquake

Likes

Dislikes

RATE

3,350 Views

Info
Bio
Chapters
Preview
Download
Zoom In

Partner:: Litquake
Location:: SF Writer's Grotto
San Francisco, CA
Event Date:: 10.10.12
Speakers:: Sonia Arrison,; David Ewing Duncan,; Paul Saffo
Tags:: aging

Summary: As part of San Francisco Litquake festival, Sonia Arrison, author of 100 Plus, David Ewing Duncan, writer of When I'm 164, join the great futurist Paul Saffo to discuss what happens to humans if the science of anti-aging succeeds.

Bio

Sonia Arrison

Sonia Arrison is a technology analyst and bestselling author of 100 Plus: How the Coming Age of Longevity Will Change Everything, From Careers and Relationships to Family and Faith. She is a founder and trustee of Singularity University.

David Ewing Duncan

David Ewing Duncan is an award-winning, best-selling author of six books and numerous essays, articles and short stories, and a television, radio and film producer and correspondent. He is the co-host of NPR's Biotech Nation.

Duncan's most recent book is Experimental Man: What one man’s body reveals about his future, your health, and our toxic world (John Wiley). His last book was Masterminds: Genius, DNA and the Quest to Rewrite Life (Harper Perennial). He also wrote the international bestseller Calendar: Humanity's Epic Struggle to Determine a True and Accurate Year (Harper-Collins/Avon), published in 19 languages, and a bestseller in 14 countries.

Duncan is a Contributing Editor to Wired, and Discover, and a science columnist for the San Francisco Chronicle, a commentator for NPR's Morning Edition and co-host of BioTech Nation on NPR. He has been a special correspondent and producer for ABC's Nightline and 20/20, and a producer for Discovery Television. He is a correspondent for NOVA's ScienceNow!. He is a regular contributor to National Geographic, Fortune and MIT Technology Review, and was a longtime correspondent for Life.

He also writes for Harper's, Atlantic Monthly, Smithsonian, Outside, The Telegraph, The Guardian, The Washington Post Book World, and The New York Times, among others. He contributes to the Dialogues column for Discover.

Paul Saffo

Paul Saffo is a forecaster and strategist with over two decades experience exploring long-term technological change and its practical impact on business and society. He was initiated into the Ancient and Honorable Order of E Clampus Vitus in 2000 and is chairman of the Most Important Committee.

Saffo is Chairman of the Samsung Science Board, and serves on a variety of other boards and advisory panels, including the Stanford Advisory Council on Science, Technology and Society, and the Long Now Foundation, as well as the boards of several public and pre-public companies located the United States and abroad. He is also a Fellow of the Royal Swedish Academy of Engineering Sciences and has served as an advisor and Forum Fellow to the World Economic Forum, which in the late 1990s named Saffo one of its "100 Global Leaders For Tomorrow."

Chapters

: Watch Full Program

01 hr 09 min 43 sec

Add to Profile
01.: David Ewing Duncan: How Long Do You Want to Live?

04 min 32 sec

Add to Profile
02.: Sonia Arrison: Bioengineering and Longevity

06 min 54 sec

Add to Profile
03.: Paul Saffo: Longevity Is Not Democratic

07 min 37 sec

Add to Profile
04.: Why Live Longer?

02 min 26 sec

Add to Profile
05.: The Science of Living Longer

07 min 24 sec

Add to Profile
06.: Technology as a Vehicle to Extend Life

05 min 11 sec

Add to Profile
07.: Longevity In Literature

05 min 59 sec

Add to Profile
08.: Upsides and Downsides to a Longer-Lived Humanity

05 min 48 sec

Add to Profile
09.: Longer Lives, Lower BIrthrates: The Coming Demographic Shift

09 min 03 sec

Add to Profile
10.: Audience Q&A

00 min 13 sec

Add to Profile
11.: Q1: Life In a Death-phobic Society

02 min 58 sec

Add to Profile
12.: Q2: Death and Religion

01 min 29 sec

Add to Profile
13.: Q3: What About Cancer?

02 min 42 sec

Add to Profile
14.: Q4: Funding Research on Aging

03 min 40 sec

Add to Profile
15.: Q5: Making Way for Future Generations

01 min 14 sec

Add to Profile
16.: Q6: Fears of Being Aged vs Fears of Being Old

00 min 37 sec

Add to Profile
17.: Final Thoughts

01 min 48 sec

Add to Profile
: Watch Full Program

01 hr 09 min 43 sec

Add to Profile

David Ewing Duncan: Why Would Anyone Want to be 150?

01 min 41 sec

Add to Profile

David Ewing Duncan, author of When I'm 164, questions the benefits of living to an advanced age. Despite medical advancement that promise greater expectancy and wellness, Duncan shares that many seniors do not wish to live to extreme ages.
Paul Saffo: What If Jobs and Einstein Lived to be 150?

02 min 53 sec

Add to Profile

Technology forecaster Paul Saffo ponders whether advancements in science and medicine would compel society to lengthen the lives of the world's greatest geniuses. Saffo also discusses the influence of people who bloomed later in life.
Watch Full Program

01 hr 09 min 43 sec

Add to Profile

Save this program for later

To download this program become a Front Row member. JOIN NOW >>

Audio (mp3)
64 MB 16 min
Video (mp4)
278 MB 1.1 hr

Select your connection speed to see approximate download times:

To download this program
become a Front Row member.

NO ADS + DOWNLOADS

ZOOM IN: Learn more with related books and additional materials.

Buy

When I'm 164: The New Science of Radical Life Extension, and What Happens If It Succeeds (Kindle Single) (TED Books)
Paul Saffo: Embracing Uncertainty: The Secret to Effective Forecasting
100 Plus: How the Coming Age of Longevity Will Change Everything, From Careers and Relationships to Family and Faith